ANCR - Ticker AI Digest

Animalcare Group Plc
332.01 | Today -0.30%
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Animalcare Group Plc in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
ANCR Data 2026-06-01 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (ANCR) 0
No same-day market news for ANCR on 2026-06-01.
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
ANCR 06:01
Animalcare Group Plc
Final Results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Animalcare Group plc, an international animal health business, reported strong financial results for the year ended 31 December 2025. Revenue increased by 20.0% to £89.1 million, driven by the significant contribution from Randlab and organic growth across all product categories. Underlying EBITDA rose by 52.6% to £17.7 million, with improved margins. Underlying profit after tax from continuing operations was £10.9 million, and underlying continuing basic EPS increased by 44.0% to 15.7 pence. The company maintained a strong cash conversion rate of 79.7% and ended the year with net debt of £9.1 million.
Strategically, Animalcare expanded its presence in Asia-Pacific through Randlab, which performed ahead of expectations, and made a 25% strategic equity investment in InVetro, an Australian Companion Animal business. The company also strengthened its product pipeline with acquisitions and partnerships, including the VHH NGF antibody programme and a license agreement for an Equine Sweet Itch treatment. R&D investment increased to 4.5% of revenue, reflecting accelerated activity.
Post-period, Animalcare announced a recommended acquisition by CCP Paw 2 Limited, a subsidiary of funds managed by Charterhouse Capital Partners LLP. The Board proposed no final dividend for 2025 due to this development. Trading since the period end has been in line with management expectations.
The companys financial performance was underpinned by strong execution, strategic progress, and the successful integration of Randlab. Animalcares growing international footprint, continued growth in leading brands, and an attractive product portfolio position it well for future growth. The acquisition by Charterhouse is expected to provide a superior outcome for stakeholders, offering a premium to recent share trading and reflecting Animalcares future growth prospects.
Financial Metric2024 (£'m)2025 (£'m)Year-on-Year Change
Revenue74.289.1+20.0%
Gross Profit41.252.4+27.2%
Underlying EBITDA11.617.7+52.6%
Net Debt (excl. lease liabilities)9.09.1+1.1%
Basic Underlying Continuing EPS (pence)10.915.7+44.0%
### Key Observations: 1. **Revenue Growth**: Revenue increased by 20.0% from £74.2m in 2024 to £89.1m in 2025, primarily driven by the acquisition of Randlab and organic growth across all product categories. 2. **Underlying EBITDA**: Underlying EBITDA saw a significant increase of 52.6% from £11.6m to £17.7m, reflecting improved operational efficiency and the contribution from Randlab. 3. **Net Debt**: Net debt remained relatively stable, increasing slightly from £9.0m to £9.1m, with leverage at 0.7 times underlying EBITDA. 4. **EPS Growth**: Basic underlying continuing EPS increased by 44.0% from 10.9 pence to 15.7 pence, driven by strong profit contributions and higher net finance income.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 10
ANCR 11:14
Animalcare Group Plc
Form 8.3
ANCR 11:35
Animalcare Group Plc
Form 8.3
ANCR 11:53
Animalcare Group Plc
Form 8.3
ANCR 14:15
Animalcare Group Plc
2025 Audited ARA, Notice of AGM & Board Changes
ANCR 10:45
Animalcare Group Plc
Form 8.3
ANCR 16:17
Animalcare Group Plc
Publication of the Scheme Document
ANCR 10:36
Animalcare Group Plc
Form 8.3
ANCR 10:21
Animalcare Group Plc
Form 8.3
ANCR 13:59
Animalcare Group Plc
Form 8.3
ANCR 06:01
Animalcare Group Plc
Final Results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Animalcare Group plc, an international animal health business, reported strong financial results for the year ended 31 December 2025. Revenue increased by 20.0% to £89.1 million, driven by the significant contribution from Randlab and organic growth across all product categories. Underlying EBITDA rose by 52.6% to £17.7 million, with improved margins. Underlying profit after tax from continuing operations was £10.9 million, and underlying continuing basic EPS increased by 44.0% to 15.7 pence. The company maintained a strong cash conversion rate of 79.7% and ended the year with net debt of £9.1 million.
Strategically, Animalcare expanded its presence in Asia-Pacific through Randlab, which performed ahead of expectations, and made a 25% strategic equity investment in InVetro, an Australian Companion Animal business. The company also strengthened its product pipeline with acquisitions and partnerships, including the VHH NGF antibody programme and a license agreement for an Equine Sweet Itch treatment. R&D investment increased to 4.5% of revenue, reflecting accelerated activity.
Post-period, Animalcare announced a recommended acquisition by CCP Paw 2 Limited, a subsidiary of funds managed by Charterhouse Capital Partners LLP. The Board proposed no final dividend for 2025 due to this development. Trading since the period end has been in line with management expectations.
The companys financial performance was underpinned by strong execution, strategic progress, and the successful integration of Randlab. Animalcares growing international footprint, continued growth in leading brands, and an attractive product portfolio position it well for future growth. The acquisition by Charterhouse is expected to provide a superior outcome for stakeholders, offering a premium to recent share trading and reflecting Animalcares future growth prospects.
Financial Metric2024 (£'m)2025 (£'m)Year-on-Year Change
Revenue74.289.1+20.0%
Gross Profit41.252.4+27.2%
Underlying EBITDA11.617.7+52.6%
Net Debt (excl. lease liabilities)9.09.1+1.1%
Basic Underlying Continuing EPS (pence)10.915.7+44.0%
### Key Observations: 1. **Revenue Growth**: Revenue increased by 20.0% from £74.2m in 2024 to £89.1m in 2025, primarily driven by the acquisition of Randlab and organic growth across all product categories. 2. **Underlying EBITDA**: Underlying EBITDA saw a significant increase of 52.6% from £11.6m to £17.7m, reflecting improved operational efficiency and the contribution from Randlab. 3. **Net Debt**: Net debt remained relatively stable, increasing slightly from £9.0m to £9.1m, with leverage at 0.7 times underlying EBITDA. 4. **EPS Growth**: Basic underlying continuing EPS increased by 44.0% from 10.9 pence to 15.7 pence, driven by strong profit contributions and higher net finance income.

Today's AI

Today's AI Starts With News

Today’s AI opens with the latest catalyst tape for ANCR.

No same-day headline has printed on 2026-06-01 yet, but the latest digestion still leads Today’s AI before the findings and blend stack below. Financial Forecastist remains wired into the blend.
Standby Tape Data 2026-06-01 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
0 Today
Front Of Desk
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the findings and blend stack below.
11:14 Latest Tape Form 8.3 11:35 Latest Tape Form 8.3 11:53 Latest Tape Form 8.3
Single-Ticker Today's AI
ANCR signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Animalcare Group Plc. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full ANCR Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for ANCR on 2026-06-01.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
229.9M
Enterprise Value
149.7M
Public Float
64.3
Broker Target
336
Shares Out
69.0M
Long Interest
100
Short Interest
0
Exchange
LSE
Currency Code
GBX
ISIN
GB0032350695
Market
LSE - AIM
Sector
Health Care
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

The alert tape opens the door for ANCR, and Financial Forecastist sits just below.

No same-day alert has printed on 2026-06-01 yet, but the latest digestion is pinned here first so the forecastist view below still opens with context instead of raw numbers.
Standby Alerts Data 2026-06-01 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
0 Alerts
Front Of Desk
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the forecastist read below.
11:14 Latest Alert Form 8.3 11:35 Latest Alert Form 8.3 11:53 Latest Alert Form 8.3
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
0.05
Ex Divi
2025-10-16
Earnings Date
2026-03-02
Net Debt
12.3M
Cash
2.9M
EPS
0.07
Net Income
5.1M
Revenue
89.1M
Enterprise Value
149.7M
Trailing PE
47.5714
Forward PE
24.0964
Price Sales TTM
2.5803
Price Book MRQ
2.0074
EV Revenue
2.7183
EV EBITDA
14.7004
Financial Forecastist

Mixed financial engine

Revenue is accelerating +20.5% against the prior comparable period. Net margin is expanding by 5.1 pts. Net debt is building +896.4%.

Revenue +20.5% Net Income -545.5% FCF +3.1% Current Ratio 1.61x Forward Rev 0
Mixed
Quarter Revenue
45.3M
+20.5%
vs prior comparable quarter
Net Margin
+4.0%
+5.1 pts
profitability pulse
Free Cash Flow
6.0M
+3.1%
cash conversion
Net Debt / EBITDA
1.5x
+896.4%
lower is cleaner
Revenue Engine

Latest quarter printed 45.3M with the top line pushing higher against the last comparable period.

Profit Stack

Net income landed at 1.8M and the margin profile is broadening. That usually tells us whether operating leverage is finally kicking in.

Balance-Sheet Pressure

Cash sits near 2.9M while net debt is 12.3M. The leverage stack is moving the wrong way.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
Q3 2023
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q1 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q2 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
Q3 2024
Consensus
0
Revenue Path
0.00
EPS / Earnings
Growth cue -
FY 2026
Consensus
93.9M
Revenue Path
0.14
EPS / Earnings
Growth cue -0.1%
FY 2027
Consensus
98.8M
Revenue Path
0.16
EPS / Earnings
Growth cue +0.1%

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q4 2025 45.3M 1.8M 6.0M 12.3M
Q2 2025 43.8M 3.3M 4.7M 11.1M
Q4 2024 37.3M -284.0K 6.5M 11.4M
Q2 2024 36.9M 32.5M 5.3M -32.0M
Q4 2023 37.6M -407.0K 5.9M 1.2M
Q2 2023 36.7M 1.6M 1.9M 4.6M

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 89.1M 5.1M 16.7M 10.7M
FY 2024 74.2M 32.2M 13.4M 11.7M
FY 2023 74.4M 1.2M 11.8M 7.7M
FY 2022 71.6M 2.0M 11.0M 6.5M
FY 2021 74.0M -77.0K 10.2M 10.8M

Structure DNA

Market Structure DNA has not been loaded for this ticker yet. Once the A15 loader runs, this desk will light up with regime labels, ownership lock, dividend cadence, and structure charts.

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
69045945
Public Hands
64.29
Institutions
-
Institutions As Of
-
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
1
Sale Director Dealing
0
Purchase TR1
0
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
0
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

Start with the latest alert tape for ANCR, then drop into AI Charts below.

No same-day headline has printed on 2026-06-01 yet, but the latest digestion is parked at the top before the chart workspace below so users can frame price, AI targets and structure from the latest tape.
Standby Tape Data 2026-06-01 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
0 Today
Catalyst Pulse
The live alert stack is quiet right now, but the latest digestion is still parked at the top before the chart read below.
11:14 Latest Tape Form 8.3 11:35 Latest Tape Form 8.3 11:53 Latest Tape Form 8.3
AI Charts Studio
ANCR Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-06-01 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
Indicators0
Technicals0
AI Forecast 86.12%
RSI Gauge
Price Change
AI Forecast